 Dr. Ornstein On Saturday June 28th Dr. Ornstein was in Korea to perform a live robotic female cystectomy during a symposium at the Seoul National University Boramae Medical Center. Following the successful surgery he was interviewed on the Arirang TV's daily talk show - "Heart to Heart." Arirang TV is Korea's first, domestically produced, English-language TV channel that is viewed in more than 51 million households in 188 countries throughout the world.
Dr. Ornstein received a BA in biochemistry from the University of Pennsylvania in 1988 and an MD from Washington University in St. Louis, MO in 1992. He completed a residency in urologic surgery at Washington University where he also was the recipient of an American Cancer Society Clinical Oncology Fellowship. Following residency, Dr. Ornstein completed a fellowship in Urologic Oncology at the National Cancer Institute, where he concentrated on both open and laparoscopic surgery for treating all forms of kidney cancer. After his fellowship, he joined the faculty of the University of North Carolina where he specialized in urologic oncology and began his research on the identification of new prostate cancer biomarkers. Following three years in North Carolina he was recruited to join the faculty in the Department of Urology at The University of California, Irvine. In September 2006 Dr. Ornstein joined the clinical staff of Long Beach Memorial Medical Center and the Todd Cancer Institute as Medical Director of Urologic Oncology and Robotic Surgery. In October 2008 Dr. Ornstein moved to Houston, Texas to assume the position of Director of Urologic Oncology in the Vanguard Urologic Instittue and the Medical Director of the Vanguard Urologic Research Foundation.
Dr. Ornstein’s career has already been highlighted by the receipt of numerous awards in recognition of his clinical and academic excellence. In 1996 he received first place in the clinical category for the resident essay contest at the annual South Central Section meeting of the American Urological Association. As an oncology fellow, Dr. Ornstein was awarded first prize for his research paper at the Clinical Sciences Fellows Symposium 2000. As faculty at the University of North Carolina, he received a Young Investigator Award from CaPCURE and the Edwin Beer Award from the New York Academy of Medicine. At the 2001 meeting of the American Urological Association, Dr. Ornstein was awarded the Best Abstract Prize in the prostate cancer category. In 2006 he was named one of the “Best Doctors” in America. In 2007, he received the “Young Investigator Award” from the Society of Urologic Oncology. This award recognizes excellence in clinical practice and/or basic research that contributed to improvement of clinical care and progress in science in the field of Urologic Oncology.
Dr. Ornstein has been named as one of "The Best Doctors in America" and a Physician of Excellence by the Orange County, California Medical Society . He has also been named as one of the America's Top Urologists by the Consumer Research Council of America.
Dr. Ornstein has received over 1 million dollars in competitive funding for prostate cancer research from federal and non-profit organizations. Dr. Ornstein has authored more than 50 scientific manuscripts, review articles and book chapters. He is an active member of the American Urological Association, American Association of Cancer Research, Society of Basic Urologic Research and The Society of Urologic Oncology. He has served on the editorial boards for Investigative Urology, Clinical Proteomics, Human Genomics and Proteomics, and on a review panel for the Department of Defense Prostate Cancer Research Program.
Although basic and translational research has always been an important aspect of Dr. Ornstein’s career his true passion is patient care. Dr. Ornstein has been and remains fully committed to providing the best possible care for patient’s with urologic malignancies. He believes that it is a privilege to help patients solve their problems and that a truthful and interactive relationship between the patient and surgeon is critical.
|
